MedAvail Holdings Inc. (MDVL) News

MedAvail Holdings Inc. (MDVL): $1.80

1.23 (-40.59%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

Add MDVL to Watchlist
Sign Up

Industry: Medical - Drug Stores

Industry

NR

Ranked

#5 of 5

in industry

Filter MDVL News Items

MDVL News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest MDVL News From Around the Web

Below are the latest news stories about MEDAVAIL HOLDINGS INC that investors may wish to consider to help them evaluate MDVL as an investment opportunity.

MedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCenters

Expands MedAvail’s presence among Federally Qualified Health Centers (FQHCs)PHOENIX, Nov. 28, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with New Orleans-based St. Thomas Community Health Centers for the deployment of two M4 MedCenter kiosks. St. Thomas operates eight Federally Qualified Health Centers (FQHCs), providing affordable health care to underserved communi

Yahoo | November 28, 2023

MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-Q

PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that on November 16, 2023, the Company received a delinquency notification letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to have timely filed its Quarterly Report on Form 10-Q for the

Yahoo | November 17, 2023

MedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 MedCenters

Initial three deployments to be completed in early 2024 at ASP Cares Pharmacy in Las Vegas Agreement repsents expansion of successful relationship with Dallas-based Oak Lawn Pharmacy PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with Pharmacy Fund 1 for the deployment of ten M4 MedCenter kiosks, which will be serviced by ASP Cares Pharmacy. Pharmacy F

Yahoo | November 17, 2023

MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference

PHOENIX, Aug. 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that Mark Doerr, Chief Executive Officer, will participate in H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023. A recording of the event will be available at 7:00am ET on September 11, 2023 on the investor relations section of MedAvail’s website at https://investors.medavail.com and will be archived for 90

Yahoo | August 30, 2023

Potential Upside For MedAvail Holdings, Inc. (NASDAQ:MDVL) Not Without Risk

There wouldn't be many who think MedAvail Holdings, Inc.'s ( NASDAQ:MDVL ) price-to-sales (or "P/S") ratio of 0.5x is...

Yahoo | August 16, 2023

MedAvail Reports Second Quarter 2023 Financial Results

PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023. “During the second quarter, we were able to sustain the positive momentum that we have experienced since we began focusing on the immense market opportunity for our pharmacy technology in January of this year,” said Mark Doerr, Chief Executive Officer of MedAvail. “Of note, we placed

Yahoo | August 14, 2023

MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters

Oak Lawn Pharmacy to deploy two M4 kiosks in 2023, with the remaining units to be deployed within 24 months of contract execution PHOENIX, Aug. 04, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with Dallas-based Oak Lawn Pharmacy to deploy ten M4 MedCenter kiosks across Texas. Per the terms of the agreement, Oak Lawn will deploy at least two M4 MedCenters in 2023, with

Yahoo | August 4, 2023

MedAvail Announces 1-for-50 Reverse Stock Split

PHOENIX, Ariz., July 31, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-50. The reverse stock split will become effective at 5:00 p.m. Eastern time, on July 31, 2023. The Company’s common stock will begin trading on a post-split basis at the market open on August 1, 2023, under the Company’s e

Yahoo | July 31, 2023

MedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health Resources

Integration allows for streamlined MedCenter deployments and an improved partner and patient experiencePHOENIX, Ariz., July 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today it has successfully achieved integration between MedAvail’s Remote Dispensing System® and its largest partner, Texas Health Resources. “The value proposition of the MedCenter extends to both clinics and patients alike, and the streamli

Yahoo | July 13, 2023

MedAvail Reports First Quarter 2023 Financial Results

PHOENIX, May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the first quarter ended March 31, 2023. “During the first quarter, we made good progress toward our mission of becoming a leader in the development and manufacture of pharmacy technology solutions in the short time since we announced the sale of certain of our SpotRx assets to CVS in January,” said Mark Doerr, Chief Executi

Yahoo | May 18, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!